Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure
J Infect. 2022 Sep;85(3):e62-e65.
doi: 10.1016/j.jinf.2022.06.012.
Epub 2022 Jun 18.
1 Department of Pediatrics, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania; Department of Clinical Immunology, National Institute for Mother and Child Health Alessandrescu-Rusescu, Lacul Tei Boulevard, 120, Bucharest, Romania.
2 Department of Clinical Immunology, National Institute for Mother and Child Health Alessandrescu-Rusescu, Lacul Tei Boulevard, 120, Bucharest, Romania.
3 Department of Clinical Immunology, National Institute for Mother and Child Health Alessandrescu-Rusescu, Lacul Tei Boulevard, 120, Bucharest, Romania. Electronic address: andreea.ioan@rez.umfcd.ro.